focus -WSS

focus

author：hotspot 2025-09-28 21:04:58 - browse：3583

The Food and Drug Administration is poised to tell drug and medical device makers how to better include people of color in the clinical trials that test whether products work and are safe, an agency official said Wednesday. Those guidelines are five months late.

To ensure that drugs work for everyone, they must be tested on a representative sample of people. But researchers have found that many clinical trials exclude the people of color who are often most affected by the diseases that drugs treat.

To help fix that problem, Congress passed a law requiring companies to give the FDA their plans for diversifying clinical trials. As part of that process, the agency was expected to issue guidance by the end of last year.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Gilead might be held responsible for not developing a drug

WSS

How digital tools helped lower hypertension in marginalized patients

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Vertex non

Wildfire pollution widens asthma inequities on Long Island

Readout LOUD podcast: How biotech is using artificial intelligence

Medicare Advantage proposed rates disappoint insurers

entertainment

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

Hollywood unions extend contract negotiations for actors

'Revelatory' study finds a smoking impact that remains after quitting

Guidelines to prevent youth baseball injuries need more muscle

The dental labor crisis is a moment of opportunity

Walensky prepares to leave CDC — and Congress — behind

The high personal cost of affirmative action for Black doctors

Medical records are filled with copy

New safety details link Apellis eye drug to rare cases of blindness

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

explore

Medical mystery: When a cough is not just a cough

Adults seen as increasingly susceptible to measles

Micronoma's microbiome cancer diagnostic approach under fire

Wildfire pollution widens asthma inequities on Long Island

Vaccine advisory panel ACIP left half staffed by HHS

5 important ways Henrietta Lacks changed medical science

entertainment

focus

explore

entertainment